Navigation Links
Elevation Pharmaceuticals Presents Positive Phase 2b Results for EP-101 in COPD Patients at the European Respiratory Society Annual Congress
Date:9/2/2012

y be added to bronchodilator treatment to improve lung function and reduce the frequency of exacerbations.  Longer-acting agents and combinations have proven successful for treating many COPD patients, but the sicker and older segment of the COPD population (15-20%) that requires nebulizer therapy is limited to shorter-acting agents and long treatment times resulting in reduced compliance and outcomes.

About Elevation Pharmaceuticals
Elevation Pharmaceuticals is a biopharmaceutical company focused on developing new inhaled therapies for patients with respiratory disease.  The company's initial focus is on developing novel therapies for the underserved subpopulation of COPD patients not able to effectively control their disease with dry powder or metered dose inhalers.  Elevation's lead drug candidate is EP-101, an inhalation solution formulation of glycopyrrolate, a long-acting muscarinic antagonist bronchodilator, in Phase 2b studies for the improved treatment of patients with severe COPD.  As announced on August 30, 2012, Elevation is being acquired by Sunovion Pharmaceuticals, Inc.  For additional information, please visit www.elevationpharma.com.

About eFlow® Technology and PARI Pharma
EP-101 is delivered by an investigational eFlow® Nebulizer System developed by PARI Pharma and optimized specifically for EP-101.  The optimized, investigational eFlow Nebulizer System uses eFlow Technology to enable highly efficient aerosolization of liquid formulations via a vibrating, perforated membrane.  Compared to other nebulization technologies, eFlow Technology produces aerosols with a very high density of active drug, a precisely defined droplet size, and a high proportion of respirable droplets delivered in a short period of time.  Combined with its quiet mode of operation, small size, light weight, and battery use, eFlow Technology reduces the burden of
'/>"/>

SOURCE Elevation Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lexicon Pharmaceuticals To Present At The Stifel Nicolaus 2012 Healthcare Conference
2. Novation Supports New Development in the U.S. Biosimilar Pharmaceuticals Market
3. Arena Pharmaceuticals to Present at Upcoming Investor Conferences
4. Isis Pharmaceuticals Demonstrates The Potential Of Single-Stranded RNA-Like Antisense Technology To Activate The RNAi Pathway
5. Optimer Pharmaceuticals to Present at September 2012 Investor Conferences
6. Global RFID in Healthcare and Pharmaceuticals Industry
7. Isis Pharmaceuticals to Present at the 2012 Stifel Nicolaus Healthcare Conference
8. MAP Pharmaceuticals, Inc. Announces Full Exercise of Underwriters Option to Purchase Additional Shares of Common Stock
9. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2012 In Boston On September 5, 2012
10. AcelRx Pharmaceuticals Receives Fourth and Fifth U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
11. Isis Pharmaceuticals to receive $1.4 million from Alnylam
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... 2014 The legalization of medical and recreational ... as a new economic driver – that has taken ... the right response to the will of the people ... At a National Press Club Newsmakers news conference ... experts in the area of marijuana legalization will discuss ...
(Date:7/14/2014)... 2014 Lumin Medical LLC, a healthcare IT ... the leading provider of on-demand patient tracking solutions and ... to Franklin, Wis. ... light and our mission is to provide visibility for ... and reduce costs," said James Hermann , President ...
(Date:7/14/2014)... 14, 2014 Valeant Pharmaceuticals International, Inc. ... today announced it has filed a premerger notification ... (HSR) with the U.S. Federal Trade Commission (FTC) ... (NYSE: AGN). About Valeant Pharmaceuticals ... Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical ...
Breaking Medicine Technology:NPC Newsmaker Program: Interpreting smoke signals from the marijuana skirmish line 2Lumin Medical Purchases PatientTrak 2Lumin Medical Purchases PatientTrak 3Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 2Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 3Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 4Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 5
... Approximately ninety-one percent of dentists say patients complaining about dry ... survey conducted by the Academy of General Dentistry (AGD). ... decrease in salivary function. It affects approximately one in ... risk for tooth decay. During the Academy of General Dentistry,s ...
... Pharmaceuticals, Inc. (Nasdaq: RIGL ) today announced that ... July 9, 2009 at 8:00 am EDT (5:00 am PDT). ... investigator of the trial will discuss results of the Company,s ... the Company,s plans for further development and related matters. ...
Cached Medicine Technology:Dry Mouth Linked to Prescription and Over the Counter Drugs 2Dry Mouth Linked to Prescription and Over the Counter Drugs 3Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis 2
(Date:7/14/2014)... 2014 Acute coronary syndrome (ACS) ... healthcare costs, frequent recurrences and hospitalizations, and high ... ACS incidence increases with age and will be ... population increases around the world. ACS is classified ... heart muscle damage inferred from a person’s symptoms, ...
(Date:7/14/2014)... 2014 Midway through summer, throngs of families ... the National Lampoon classic “Vacation.” An estimated four out of ... by Bridgestone Americas , embark on summer road trips. And ... nagging back pain as the result of hours cramped behind ... , “For these patients, riding in a car for an ...
(Date:7/14/2014)... Institutes of Health (NIH) have identified genetic markers associated ... characterized by high levels of immune cells called eosinophils ... are involved in the development of EoE, which can ... allergies. The findings also may help explain why the ... in part by the Consortium of Food Allergy ...
(Date:7/14/2014)... A recent study published in the July 2014 ... of Child and Adolescent Psychiatry confirms the validity ... criterion for diagnosis of attention-deficit/hyperactivity disorder (ADHD). , In ... at 7 in DSM-IV, has been raised to 12. ... set at 12, rather than an earlier age, to ...
(Date:7/14/2014)... years that have passed since acupuncture was first ... used to treat a number of physical, mental ... rehabilitation, headaches, menstrual cramps, asthma, carpal tunnel, fibromyalgia ... Now, a meta-analysis of randomized controlled trials which ... , the journal of The North American Menopause ...
Breaking Medicine News(10 mins):Health News:Acute Coronary Syndrome (ACS) Incident Cases to Reach 1.47 million by 2023, Says a New Report Available at ReportsnReports.com 2Health News:Acute Coronary Syndrome (ACS) Incident Cases to Reach 1.47 million by 2023, Says a New Report Available at ReportsnReports.com 3Health News:Acute Coronary Syndrome (ACS) Incident Cases to Reach 1.47 million by 2023, Says a New Report Available at ReportsnReports.com 4Health News:Top Orthopedic Surgeon Shares Seven Ways To Reduce Back Pain During Long Summer Road Trips 2Health News:Top Orthopedic Surgeon Shares Seven Ways To Reduce Back Pain During Long Summer Road Trips 3Health News:Scientists deepen genetic understanding of eosinophilic esophagitis 2Health News:Bothered by hot flashes? Acupuncture might be the answer 2
... and his colleagues from the Stanford University School of Medicine ... Cancer Research. The result of the study has found that ... to reduce the growth of cancer in patients with prostate ... two drugs reduces the growth of prostate cancer by 70 ...
... researchers from University of South Florida had reported in ... Sciences that the more nature of mental exercise performed ... reducing the risk of dementia in later life.// ... lifetime occupation and risk for Alzheimer’s disease and dementia ...
... Kolkata (6th Sept 2005): In an alarming announcement the ... that West Bengal was facing a Dengue epidemic and the ... last year.// ,Mishra also said that other than ... the people, especially in Kolkata. ,Dengue was also ...
... low dose of Vitamin D with non-steroidal anti- inflammatory ... says a study.// ,David Feldman and other researchers ... a form of Vitamin D, combined with an over-the-counter ... online edition of Ivanhoe Broadcast News. ,The researchers ...
... of had discovered a new way to test the ... attack. // ,The researchers had used a ... cells’ destinations after being injected into the body to ... attack. ,In the study, researchers surgically ...
... from anorexia nervosa have the similar brain activities that ... study was published in the September issue of Archives ... alterations in the activity of serotonin (a brain chemical ... the appetite alteration in anorexia nervosa as well as ...
Cached Medicine News:
... Selecta Duo Adding the ... platform creates the Selecta Duo, ... nm Photocoagulator combination laser that ... involving both the anterior segment ...
Patient-Centered Therapy that promotes natural cardiac function....
... The Apeel CS Catheter Delivery System ... used for the placement of permanent ... Apeel CS Catheter Delivery System is ... torqueability, flexibility, and softness, plus high ...
... Alliance Catheter Delivery System (CDS) ... stabilization of the Aescula LV ... has a patented coronary sinus ... and easy access to the ...
Medicine Products: